Quantapore is at the forefront of advancing proteomics through the development of innovative analytical platforms that utilize single-molecule, solid-state nanopore technology. This approach allows for massively parallel analysis of proteins at the single-molecule level, which is a significant leap forward in the field. By addressing critical challenges faced by researchers today, Quantapore aims to enhance the understanding of proteomics and genomics, ultimately contributing to improved human health outcomes.

The company's focus on direct protein analysis through nanopore-based tools positions it to make a substantial impact in scientific research. These technologies are designed to provide more accurate and efficient methods for studying proteins, which are essential for various biological processes. By leveraging their expertise in nanotechnology, Quantapore is committed to transforming the landscape of protein analysis, paving the way for breakthroughs in both research and clinical applications.

United States

Quantapore Inc. is developing a nanopore based nucleic acid sequencing technology thatutilizes an optical read out which results in lower cost and higher throughput compared to electrical data acquisition.

Quantapore

Company Details